Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1100 of 2228 entries
View as:

This Study Tests BI 1467335 in Healthy Japanese and Caucasian Men. The Study Tests How Different Doses of BI 1467335 Are Taken up in the Body and How Well They Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT03159455 Org: User:
Start: 06/07/17 End: 12/16/17 Due: 12/16/18

Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253849 Org: User:
Start: 11/30/05 End: - Due: -

Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02262572 Org: User:
Start: 04/30/03 End: - Due: -

A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.

Phase: N/A Priority: Normal
NCT ID: NCT03927209 Org: User:
Start: 06/06/19 End: 11/22/19 Due: 11/22/20

SMS Reminder to Assess Adherence

Phase: N/A Priority: Normal
NCT ID: NCT01308476 Org: User:
Start: 03/31/11 End: - Due: -

Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache

Phase: N/A Priority: Normal
NCT ID: NCT02183220 Org: User:
Start: 10/31/98 End: - Due: -

Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02225626 Org: User:
Start: 09/30/14 End: 12/31/14 Due: 12/31/15

Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT01233284 Org: User:
Start: 11/30/10 End: - Due: -

Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00157235 Org: User:
Start: 09/30/02 End: 04/30/06 Due: 04/30/07

BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01121393 Org: User:
Start: 04/19/10 End: 11/26/17 Due: 11/26/18

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Mono Products of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02222428 Org: User:
Start: 04/30/09 End: - Due: -

Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171052 Org: User:
Start: 06/30/06 End: - Due: -

Relative Bioavailability of BI 10773 Administered Twice Daily Compared BI 10773 Given Once Daily After Multiple Oral Doses in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02782624 Org: User:
Start: 09/30/09 End: 11/30/09 Due: 11/30/10

Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT02238249 Org: User:
Start: 10/31/05 End: - Due: -

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00340704 Org: User:
Start: 04/30/06 End: 06/30/09 Due: 06/30/10

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01023958 Org: User:
Start: 11/19/09 End: 09/19/11 Due: 09/19/12

Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264067 Org: User:
Start: 07/31/98 End: - Due: -

Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

Phase: N/A Priority: Normal
NCT ID: NCT02243566 Org: User:
Start: 04/30/06 End: - Due: -

Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01737996 Org: User:
Start: 11/30/12 End: 03/31/13 Due: 03/31/14

BIBW 2992 Administered as Tablet (Final Formulation) Compared to BIBW 2992 Drinking Solution and BIBW 2992 Tablet (Trial Formulation II) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171715 Org: User:
Start: 01/31/09 End: - Due: -

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01975220 Org: User:
Start: 10/31/13 End: 12/31/13 Due: 12/31/14

BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT00949650 Org: User:
Start: 08/14/09 End: 03/16/17 Due: 03/16/18

Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253875 Org: User:
Start: 11/30/05 End: - Due: -

Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02261090 Org: User:
Start: 06/30/04 End: - Due: -

Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

Phase: N/A Priority: Normal
NCT ID: NCT00034840 Org: User:
Start: 10/31/01 End: 08/31/02 Due: 08/31/03